Merger With Warner Chilcott Expected To Turn Actavis Into #3 Specialty Pharma In U.S.
This article was originally published in The Pink Sheet Daily
Executive Summary
The rumored combination of Actavis and Warner Chilcott, with Actavis to re-domicile as an Irish firm for tax benefits, came to fruition May 20. Warner Chilcott CEO Boissonneault said the deal resulted from a long friendship with Actavis’ Bisaro and did not come together overnight.